Obalon Therapeutics Stock Short Ratio
Obalon Therapeutics fundamentals help investors to digest information that contributes to Obalon Therapeutics' financial success or failures. It also enables traders to predict the movement of Obalon Stock. The fundamental analysis module provides a way to measure Obalon Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Obalon Therapeutics stock.
Obalon |
Obalon Therapeutics Company Short Ratio Analysis
Obalon Therapeutics' Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
Current Obalon Therapeutics Short Ratio | 0.83 X |
Most of Obalon Therapeutics' fundamental indicators, such as Short Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Obalon Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
CompetitionBased on the latest financial disclosure, Obalon Therapeutics has a Short Ratio of 0.83 times. This is 78.72% lower than that of the Healthcare sector and 77.98% lower than that of the Medical Devices industry. The short ratio for all United States stocks is 79.25% higher than that of the company.
Obalon Short Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Obalon Therapeutics' direct or indirect competition against its Short Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Obalon Therapeutics could also be used in its relative valuation, which is a method of valuing Obalon Therapeutics by comparing valuation metrics of similar companies.Obalon Therapeutics is currently under evaluation in short ratio category among related companies.
Obalon Fundamentals
Return On Equity | -120.25 | |||
Return On Asset | -45.53 | |||
Operating Margin | (711.27) % | |||
Current Valuation | 22.07 M | |||
Shares Outstanding | 10.02 M | |||
Shares Owned By Insiders | 3.23 % | |||
Shares Owned By Institutions | 30.70 % | |||
Number Of Shares Shorted | 354.36 K | |||
Price To Earning | (3.73) X | |||
Price To Book | 5.07 X | |||
Price To Sales | 19.25 X | |||
Revenue | 1.59 M | |||
Gross Profit | 531 K | |||
EBITDA | (10.96 M) | |||
Net Income | (12.33 M) | |||
Cash And Equivalents | 3.9 M | |||
Cash Per Share | 0.39 X | |||
Total Debt | 1.43 M | |||
Debt To Equity | 0.31 % | |||
Current Ratio | 1.55 X | |||
Book Value Per Share | 0.60 X | |||
Cash Flow From Operations | (10.41 M) | |||
Short Ratio | 0.83 X | |||
Earnings Per Share | (1.59) X | |||
Beta | -1.22 | |||
Market Capitalization | 30.56 M | |||
Total Asset | 78.78 M | |||
Retained Earnings | (176.97 M) | |||
Working Capital | 73.47 M | |||
Current Asset | 78.06 M | |||
Current Liabilities | 4.59 M | |||
Z Score | 9.8 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Consideration for investing in Obalon Stock
If you are still planning to invest in Obalon Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Obalon Therapeutics' history and understand the potential risks before investing.
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |